Acetyl-l-Carnitine and Oxfenicine on Cardiac Pumping Mechanics in Streptozotocin-Induced Diabetes in Male Wistar Rats

Abstract

Introduction

In the treatment of patients with diabetes, one objective is an improvement of cardiac metabolism to alleviate the left ventricular (LV) function. For this study, we compared the effects of acetyl- l-carnitine (one of the carnitine derivatives) and of oxfenicine (a carnitine palmitoyltransferase-1 inhibitor) on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats, with a particular focus on the pressure-flow-volume relationship.

Methods

Diabetes was induced by a single tail vein injection of 55 mg kg ⁻¹ streptozotocin. The diabetic animals were treated on a daily basis with either acetyl-L-carnitine (1 g L ⁻¹ in drinking water) or oxfenicine (150 mg kg ⁻¹ by oral gavage) for 8 wk. They were also compared with untreated age-matched diabetic controls. LV pressure and ascending aortic flow signals were recorded to calculate the maximal systolic elastance ( E _max) and the theoretical maximum flow ( Q _max). Physically, E _max reflects the contractility of the myocardium as an intact heart, whereas Q _max has an inverse relationship with the LV internal resistance.

Results

When comparing the diabetic rats with their age-matched controls, the cardiodynamic condition was characterized by a decline in E _max associated with the unaltered Q _max. Acetyl- l-carnitine (but not oxfenicine) had reduced cardiac levels of malondialdehyde in these insulin-deficient animals. However, treating with acetyl- l-carnitine or oxfenicine resulted in an increase in E _max, which suggests that these 2 drugs may protect the contractile status from deteriorating in the diabetic heart. By contrast, Q _max showed a significant fall after administration of oxfenicine, but not with acetyl-L-carnitine. The decrease in Q _max corresponded to an increase in total vascular resistance when treated with oxfenicine.

Conclusions

Acetyl- l-carnitine, but not oxfencine, optimizes the integrative nature of cardiac pumping mechanics by preventing the diabetes-induced deterioration in myocardial intrinsic contractility associated with unaltered LV internal resistance.